Join Andrew Warmington, Manufacturing Editor at Citeline, in conversation with Tom Hickey, Director of Therapeutic Strategy at Novotech, a global full-service clinical CRO dedicated to accelerating the development of advanced and novel therapeutics.
In this episode, recorded live at the European Association for the Study of the Liver Congress (EASL) in Amsterdam, Tom shares invaluable insights into the evolving landscape of hepatology clinical trials and the unique challenges and opportunities shaping the field today.
Key Highlights:
- The Rising Importance of Hepatology: Learn why liver diseases like hepatitis B, HCC, and NASH are gaining attention globally.
- Tailored Approaches for Biotechs: Discover how Novotech’s partnership-driven model supports smaller biotech companies in navigating clinical complexities.
- AI & Innovation: Explore how artificial intelligence is reshaping trial design, site selection, and patient engagement in hepatology studies.
- Global Trial Execution: Gain insights into managing logistics and supply chain challenges amid geopolitical shifts.
